Idexx Laboratories (IDXX) Change in Account Payables (2009 - 2026)

Idexx Laboratories has reported Change in Account Payables for 18 years, with the latest figure at -$6.7 million in Q2 2026.

• On a quarterly basis, Change in Account Payables fell 68.82% year-over-year to -$6.7 million in Q2 2026; TTM through Jun 2026 was $8.0 million, a 202.45% increase from a year earlier, with the FY2025 full-year figure at -$8.6 million, down 206.02% from the prior year.
• Change in Account Payables was -$6.7 million for Q2 2026 at Idexx Laboratories, down from $11.2 million in the prior quarter.
• The five-year high for Change in Account Payables was $11.2 million in Q1 2026, with the low at -$8.1 million in Q1 2025.
• Average Change in Account Payables over 5 years is $383555.6, with a median of -$2.0 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Change in Account Payables sank 301.11% in 2022, then surged 590.45% in 2025.
• Over 5 years, Change in Account Payables stood at $7.4 million in 2022, then declined by 15.61% to $6.2 million in 2023, then declined by 8.06% to $5.7 million in 2024, then tumbled by 162.66% to -$3.6 million in 2025, then plunged by 87.32% to -$6.7 million in 2026.
• The last three Change in Account Payables figures came in at -$6.7 million (Q2 2026), $11.2 million (Q1 2026), and -$3.6 million (Q4 2025), per Business Quant data.